Key Takeaways
- Most de-SPAC transactions use a combined proxy statement and prospectus on Form S-4, which simultaneously registers the shares issued to target equity holders under the Securities Act and solicits SPAC shareholder approval under the Exchange Act. Understanding which registration form governs and what each component requires is foundational to structuring the disclosure correctly.
- The SEC's 2024 SPAC rules added Item 1609 to Regulation S-K, which imposes specific disclosure obligations on any financial projections included in a SPAC proxy or S-4, including disclosure of the assumptions underlying the projections and whether those projections were used in any fairness determination. These rules materially increased the disclosure burden and litigation exposure associated with projection disclosure in de-SPAC transactions.
- Sponsor and director conflict disclosure is one of the most scrutinized sections of the SPAC proxy. The SEC staff consistently comments on inadequate disclosure of the sponsor's promote economics, the potential for sponsor conflicts in evaluating the target, and the board's process for managing those conflicts in its fairness determination.
- Redemption right mechanics and the applicable deadline must be disclosed with precision. Errors in the redemption procedures disclosed in the proxy can expose the SPAC to claims from shareholders who failed to redeem because the procedures were inadequately described, and can create closing risk if redemptions exceed the maximum threshold and the SPAC lacks alternative financing to satisfy minimum cash conditions.
The proxy statement and Form S-4 registration statement filed in connection with a SPAC de-SPAC merger are among the most complex disclosure documents in U.S. securities practice. They combine the registration of new securities under the Securities Act with the shareholder solicitation requirements of the Exchange Act, overlay the SEC's 2024 SPAC-specific disclosure rules, incorporate the target company's full business description and historical and pro forma financial statements, and must address the structural conflicts that are inherent in virtually every SPAC transaction. The document is simultaneously the legal record of the board's decision-making process, the investor disclosure that governs Section 11 liability, and the instrument through which shareholders exercise their redemption rights.
This sub-article is part of the SPAC and De-SPAC Transactions: Legal Guide. It covers the full structure and content requirements of the SPAC proxy and S-4 in detail: the choice between Form S-4 and Schedule 14A and when each applies; the target business description and combined company risk factors; MD&A on historical and pro forma financials; projection disclosure under the SEC's 2024 rules; Section 11 liability considerations; sponsor and director conflict disclosure; fairness considerations, board process, and the role of fairness opinions; related party transaction and executive compensation disclosure; shareholder vote thresholds and procedures; redemption right mechanics; SEC review and comment cycles; the effective date, record date, and mailing requirements; vote solicitation and the role of proxy advisory firms; and post-vote closing mechanics.
Acquisition Stars advises SPAC sponsors, targets, and their respective boards on de-SPAC proxy and S-4 preparation, SEC comment letter strategy, and transaction execution. Nothing in this article constitutes legal advice for any specific transaction.
Form S-4 vs. Schedule 14A: Structure and When Each Applies
The choice between filing on Form S-4 and filing only a Schedule 14A proxy statement depends on whether the de-SPAC transaction involves the issuance of new registered securities to target equity holders. Form S-4 is a Securities Act registration statement used for securities issued in business combination transactions, including mergers where the surviving entity's shares are distributed to the selling entity's shareholders. Schedule 14A is the Exchange Act proxy statement form used whenever a company solicits shareholder votes, including votes on mergers, acquisitions, and other significant transactions.
In a typical de-SPAC merger, the SPAC issues its own shares (or the shares of a new combined holding company) to the target's existing equity holders as merger consideration. Those shares must be registered under the Securities Act because they are being offered and sold in connection with the transaction. Form S-4 is the registration form designated for that purpose, and it incorporates the proxy statement as a prospectus. The combined document filed on Form S-4 simultaneously satisfies the registration requirement under the Securities Act and the proxy solicitation requirements under the Exchange Act, subject to both sets of rules and their respective disclosure standards.
A Schedule 14A without a Form S-4 may be used when the de-SPAC transaction does not involve the issuance of registered securities to target stockholders, for example in a transaction structured as a tender offer for the target followed by a back-end merger where no new shares are issued to target holders, or in certain UP-C structures where the economic interests in the combined entity are not registered securities. These structures are less common but require careful analysis of whether any securities issued in the transaction require registration, because the failure to register securities that should be registered triggers Securities Act liability.
Schedule 14A governs the solicitation mechanics regardless of whether a Form S-4 is also filed. The proxy statement component of the Form S-4 must comply with Regulation 14A, including the requirements for the form of proxy, the notice of meeting, the record date procedures, the mailing obligations, and the vote solicitation rules. The Form S-4 registration component must comply with the Securities Act registration requirements, including the financial statement requirements of Regulation S-X, the disclosure requirements of Regulation S-K as modified by the Form S-4 instructions, and the SEC's 2024 SPAC-specific rules.
Target Business Description and Risk Factors for the Combined Company
The SPAC proxy and S-4 must include a comprehensive description of the target company's business, because the SPAC's public shareholders are being asked to vote on whether the SPAC should acquire a company that was private at the time of the SPAC IPO and about which they had no information when they invested. The target business description follows the requirements of Item 101 of Regulation S-K and must provide sufficient detail for a reasonable investor to assess the nature of the target's operations, its competitive position, its key products or services, its markets, and the regulatory framework applicable to its business.
The business description must identify the material factors that make the target business valuable to the SPAC and must explain the strategic rationale for the combination. This is not merely a marketing document: the SEC staff reviews the business description for consistency with the financial disclosures, risk factors, and MD&A, and comments extensively on business descriptions that are inconsistent with the financial performance disclosed elsewhere. If the business description presents the target as a high-growth company with strong competitive advantages, but the financial statements show flat revenue and declining margins, the SEC staff will require reconciliation of the inconsistency.
Risk factors for the combined company must cover both the risks specific to the target's business and the risks created by the transaction structure itself. Transaction-specific risks include the risk that key employees of the target will not remain with the combined company, the risk that the combined company will be unable to integrate the SPAC's public company compliance infrastructure with the target's operations, and the risk that redemptions will reduce the trust proceeds available to fund the combined company's business plan. Risk factors must also address the structural features of the SPAC that may create post-closing conflicts or complications, including any earn-out provisions, warrant liabilities, or sponsor lock-up arrangements that survive the closing.
MD&A on Historical and Pro Forma Financials
The SPAC proxy and S-4 must include MD&A covering the target company's historical financial results for each period presented in the financial statements, following the requirements of Item 303 of Regulation S-K. Because most de-SPAC targets have not previously been subject to SEC reporting requirements, the historical MD&A is often the first time the target has prepared a full public-company-quality MD&A, and it frequently requires significant work to meet the standard the SEC staff expects.
The historical MD&A must cover results of operations for each fiscal year and interim period presented in the financial statements, with a qualitative explanation of the factors driving changes in revenue, operating expenses, and net income or loss from period to period. It must also cover liquidity and capital resources, critical accounting estimates, and known trends and uncertainties that are reasonably likely to have a material effect on the combined company's future financial condition or results of operations. Target companies that have relied on non-standard revenue recognition practices, non-GAAP metrics, or aggressive accounting positions during their private company period frequently encounter SEC comments on the adequacy of the critical accounting estimate disclosure.
The pro forma financial statements required in a Form S-4 present the combined financial position of the SPAC and target as if the transaction had occurred at the beginning of the earliest period presented, adjusted for the effects of the transaction accounting. Pro forma statements must comply with Article 11 of Regulation S-X, which was revised in 2020 to require management's adjustments reflecting the expected synergies, restructuring charges, and other transaction effects in addition to the mandatory accounting adjustments required under ASC 805. The MD&A must address the pro forma financials, explaining the material transaction accounting adjustments and their effect on the combined company's financial profile.
Projection Disclosure Under SEC 2024 Rules (Item 1609 of Regulation S-K)
Financial projections have historically been a defining feature of de-SPAC transaction disclosure, because SPAC sponsors and targets use forward-looking financial models to justify the valuation at which the transaction is priced. The SEC's 2024 SPAC rules added Item 1609 to Regulation S-K specifically to address the disclosure obligations that arise when projections are included in a SPAC proxy or S-4, imposing a framework that materially increased both the disclosure burden and the potential litigation exposure associated with projection disclosure.
Under Item 1609, a registrant that includes financial projections in a SPAC proxy or S-4 must disclose: the purpose for which the projections were prepared; the material assumptions underlying each projection; whether the projections represent management's views at the time of filing or were prepared solely for purposes of the transaction; whether the projections were provided to the SPAC's financial advisor and, if so, whether and how the advisor used them in any fairness or valuation analysis; and a statement of the material factors that could cause actual results to differ materially from the projected amounts. The issuer must also disclose whether the board relied on the projections in evaluating the transaction and forming its recommendation to shareholders.
The practical effect of Item 1609 is that projections in a SPAC proxy now receive the same level of specific disclosure scrutiny as the historical financial statements. Sponsors who previously included a single revenue and EBITDA projection table without supporting disclosure now must expose the full analytical basis for those projections to SEC staff review and potential investor scrutiny. Projections that are inconsistent with the target's historical financial trajectory, that rely on assumptions not grounded in the target's actual operational experience, or that present best-case scenarios as base cases have been the subject of SEC comment letters requiring revision or deletion.
The 2024 rules also modified the safe harbor for forward-looking statements in the SPAC context. The Private Securities Litigation Reform Act safe harbor for forward-looking statements, which protects companies that accompany projections with meaningful cautionary language identifying material factors that could cause actual results to differ, was previously available for projections included in a SPAC proxy. The 2024 rules restricted this safe harbor for certain SPAC-specific forward-looking statements, increasing the litigation risk profile of projection disclosure in de-SPAC transactions.
Forward-Looking Statement Liability Under Section 11
Section 11 of the Securities Act imposes strict liability on the issuer for any material misstatement or omission in a registration statement as of its effective date, and imposes liability on signatories and experts unless they can establish the due diligence defense. In the de-SPAC context, the Form S-4 registration statement is the liability-bearing document, and the SPAC (as registrant), its directors who sign the registration statement, and experts (auditors and financial advisors who consent to the inclusion of their reports) are all potentially subject to Section 11 claims.
Financial projections included in the Form S-4 registration statement are particularly significant from a Section 11 perspective because they are included in a registered document and are therefore subject to Securities Act liability standards. This is a materially different liability exposure than projections included in an investor presentation that is not part of a registered offering. Issuers and their counsel must evaluate whether each projection included in the S-4 was made with a reasonable basis and in good faith, and whether the assumptions disclosed are sufficient to allow investors to evaluate the reasonableness of the projection.
The due diligence defense available to SPAC directors who are not officers of the company requires that they conduct a reasonable investigation of the disclosure in the registration statement. In practice, SPAC directors who are not operationally involved with the target must rely on management representations and the work product of the SPAC's counsel, financial advisors, and due diligence team. The adequacy of the diligence process, the independence of the advisors, and the extent to which the board reviewed and challenged the disclosure are all relevant to whether the due diligence defense would be available if a Section 11 claim is asserted after closing.
Sponsor and Director Conflicts Disclosure
Conflict of interest disclosure is the most scrutinized section of most SPAC proxies. The structural features of the SPAC create conflicts that are inherent in virtually every de-SPAC transaction: the sponsor holds founder shares (the "promote") that are typically acquired for nominal consideration and will only have value if the SPAC completes a business combination before the deadline, creating strong economic incentives for the sponsor to complete a transaction even on terms that may not be optimal for public shareholders. The sponsor also typically holds private placement warrants that will only have value if the combined company's stock price exceeds the warrant exercise price after closing.
The proxy must disclose the sponsor's promote structure in quantitative detail, including the number of founder shares held by the sponsor, the price paid for those shares, the conditions under which those shares will vest or be subject to forfeiture, and the estimated value of the promote at different assumed share prices. The SEC staff requires that this disclosure be presented in terms that allow public shareholders to understand the sponsor's economic incentive to complete the transaction, including the approximate dollar amount of value the sponsor stands to gain at the assumed transaction price and the amount the sponsor would lose if the SPAC fails to complete a transaction and liquidates.
Director conflicts must be disclosed at the individual level. Any director who has a financial relationship with the target, a business relationship with the target's controlling shareholders, or a material interest in the transaction that differs from the interest of public shareholders must be identified and the nature of the conflict must be described with specificity. The proxy must also describe the process by which the board managed conflicts in evaluating and approving the transaction, including any recusals, the use of independent committees, and whether conflicted directors participated in the fairness determination.
Fairness Considerations, Board Process, and Fairness Opinion Scope
The SPAC board's determination that the transaction is fair to and in the best interests of the SPAC's public shareholders must be described in the proxy statement in sufficient detail that shareholders can evaluate the adequacy of the board's process. The proxy must identify the factors the board considered in making this determination, including the valuation of the target, the terms of the merger agreement, the projected financial performance of the combined company, the alternatives to the transaction that the board considered, and the board's assessment of the risks of the transaction compared to the risks of failing to complete a combination before the SPAC's deadline.
While a fairness opinion is not legally required, the proxy must disclose whether a fairness opinion was obtained and, if so, must include a summary of the opinion and the key analyses performed by the financial advisor. The financial advisor's consent to the inclusion of the opinion summary in the proxy must be filed as an exhibit to the registration statement. If no fairness opinion was obtained, the proxy must explain the basis on which the board determined the transaction to be fair without one, which requires a more detailed articulation of the board's independent analytical process.
Where a fairness opinion is obtained, its scope is a critical disclosure item. A fairness opinion in a de-SPAC transaction typically addresses whether the consideration to be paid by the SPAC is fair from a financial point of view to the SPAC's public shareholders as a class. The opinion does not opine on the adequacy of consideration for individual shareholders with different economic positions (such as shareholders who hold both public shares and warrants), nor does it opine on whether shareholders should approve the transaction or exercise their redemption rights. The proxy must make these limitations of the opinion's scope clear to shareholders so they understand what the fairness opinion does and does not address.
Related Party Transactions and Target Executive Compensation Disclosure
Related party transaction disclosure in the SPAC proxy must cover both the SPAC's related party transactions and the target's related party transactions for the periods covered by the financial statements. Item 404 of Regulation S-K requires disclosure of any transaction involving the registrant in which a related person had a material interest and the amount involved exceeded $120,000. For the SPAC, the most significant related party transactions typically include: the founder share issuance to the sponsor; any promissory notes or working capital loans from the sponsor to the SPAC; the private placement warrant purchase; and any administrative services agreements pursuant to which the SPAC paid fees to sponsor-affiliated entities.
For the target, related party transactions may include compensation arrangements with founder-controlled entities, intellectual property licenses, service agreements with entities in which the target's founders or significant shareholders have interests, and any transactions with the SPAC or its sponsor that occurred during the negotiation period. The SEC staff pays particular attention to transactions between the SPAC or its sponsor and the target that may have influenced the valuation or the board's recommendation, and requires disclosure of any such transactions with specificity about the amounts involved and the terms on which they were negotiated.
Target executive compensation disclosure must be included in the proxy under the requirements applicable to the target's reporting status and size. The proxy must describe the compensation arrangements for the target's named executive officers for the most recent completed fiscal year, including the Summary Compensation Table, information about outstanding equity awards, and any arrangements related to the transaction itself, such as single-trigger or double-trigger equity acceleration provisions, retention bonuses, or change-in-control payments. Transaction-related compensation arrangements must also be disclosed under Item 402(t) of Regulation S-K in the "golden parachute" table, which quantifies each element of compensation that each named executive officer could receive in connection with the transaction.
Shareholder Vote Thresholds and Redemption Right Procedures
The shareholder vote threshold required for approval of a de-SPAC merger depends on the law of the SPAC's state of incorporation and the terms of the SPAC's charter. Most SPACs are incorporated in Delaware, where the General Corporation Law requires approval of a merger by the holders of a majority of the outstanding shares entitled to vote. However, many SPAC charters impose higher approval thresholds for specific provisions, or require separate class votes if the merger treats different classes of shareholders differently. The proxy must accurately describe the applicable vote threshold and explain what happens if the threshold is not met.
Shareholder vote thresholds interact with the redemption right in a significant way. Public shareholders may vote against the merger and still redeem their shares, or may vote for the merger and redeem their shares, because the right to redeem is independent of the direction of the vote in most SPAC structures. This means that the SPAC must achieve both the required vote threshold and a level of redemptions below the maximum redemption threshold in order for the transaction to close. The proxy must disclose the maximum redemption threshold (typically a percentage of public shares above which the SPAC charter prohibits closing) and the consequences if that threshold is exceeded.
The redemption right procedure must be described in precise mechanical detail. The proxy must specify the per-share redemption price (calculated as the pro rata portion of the trust account, including accrued interest), the deadline for tendering shares (typically two business days before the meeting), the mechanics of tendering through DTC (including the specific DTC participant instructions and deadline), and the procedure for withdrawing a redemption election before the deadline. The proxy must also disclose that shareholders who fail to tender by the deadline forfeit their redemption right for that meeting, even if they vote against the transaction.
SEC Review and Comment Cycles: Effective Date and Record Date
The SEC's Division of Corporation Finance reviews all SPAC Form S-4 and proxy filings. The review process for a SPAC S-4 proxy follows the same general structure as any registration statement review: the SEC staff issues a comment letter identifying deficiencies or requesting additional disclosure, the issuer responds in writing and files an amendment to the registration statement incorporating any required changes, and the process continues until the staff issues a no-further-comment letter. For proxy-only filings on Schedule 14A, the SEC staff has 10 days to notify the registrant of any comments it intends to issue; for registered filings on Form S-4, the staff issues comments within 30 days of filing.
The record date for the shareholder meeting must be set before the proxy is mailed to shareholders, and typically is set 20 to 60 days before the meeting date. The record date determines which shareholders are entitled to vote and to receive the mailed proxy materials. Because the trust account accrues interest over time, the per-share redemption price stated in the proxy is an estimate calculated as of a recent date, and the actual redemption price paid to redeeming shareholders will reflect interest accrued through the closing date. The proxy must describe this calculation clearly so that shareholders understand that the final redemption price may differ slightly from the estimate in the proxy.
The registration statement becomes effective upon the SEC declaring it effective under Section 8(a) of the Securities Act. The registration statement must be effective before the proxy materials are distributed to shareholders and before the shareholder vote is held. For SPAC transactions where the proxy also serves as a prospectus for the shares issued to target equity holders, effectiveness must occur before those shares are distributed at closing. The practical sequencing is therefore: SEC comments resolved, registration statement declared effective, proxy mailed to shareholders, meeting held, vote obtained, and (if approved) transaction closes with simultaneous share issuance to target holders.
Distribution to Shareholders, Mailing Requirements, and Vote Solicitation
Exchange Act Rule 14a-16 governs the "notice and access" method by which public companies may satisfy their proxy delivery obligations by posting proxy materials to a publicly accessible website and mailing a notice to shareholders directing them to the website. SPAC proxies may use the notice and access method, but the notice must be mailed at least 40 days before the shareholder meeting, which is a longer lead time than the 10-day minimum that applies for full proxy delivery. Given that SPAC transactions operate under time pressure from the SPAC deadline, many sponsors elect to use full delivery (mailing the complete proxy) rather than notice and access to reduce the minimum notice period to 10 days, though 10 days is practically insufficient for most institutional investors to review and act on proxy materials.
Vote solicitation in a SPAC transaction typically involves engagement with institutional shareholders by the SPAC's proxy solicitor, who contacts holders of record and beneficial holders to encourage them to vote and to address questions about the transaction. The proxy solicitor's fees must be disclosed in the proxy statement. The proxy statement itself must comply with Regulation 14A's anti-fraud and completeness requirements, which prohibit false or misleading statements in any proxy solicitation materials and require that the proxy present a balanced and accurate description of the transaction and the board's recommendation.
ISS and Glass Lewis evaluate SPAC proxies against their published voting guidelines for business combination transactions. ISS's guidelines for SPACs assess: the quality and completeness of the disclosure, including the adequacy of the target business description and financial disclosure; the fairness of the transaction economics, including the sponsor promote as a percentage of the total transaction value; whether the trust account has been maintained without disbursement; whether the board sought a fairness opinion; and whether the transaction was completed within the SPAC's stated deal timeline. Glass Lewis similarly focuses on sponsor economics, board composition and independence, the quality of the fairness process, and the adequacy of the disclosure. Negative recommendations from either firm can materially increase redemptions and reduce the likelihood the transaction closes on the planned timeline.
Post-Vote Closing Mechanics
After the shareholders vote to approve the merger and the transaction clears the maximum redemption threshold, the parties must satisfy any remaining closing conditions specified in the merger agreement before the transaction can close. Common closing conditions in de-SPAC transactions include: Hart-Scott-Rodino antitrust clearance (if applicable based on deal size and the target's industry); expiration of any applicable lock-up or consent periods under the target's material contracts; delivery of officer certificates confirming the accuracy of representations and warranties; delivery of legal opinions from counsel to each party; and the absence of any legal injunction preventing the closing.
The trust account release is a central component of the closing mechanics. The SPAC's trust agreement governs the conditions under which the trustee is authorized to release funds from the trust, which typically require a certification from the SPAC that the conditions for closing have been satisfied. Funds from the trust flow to three destinations: the pro rata redemption amounts payable to redeeming shareholders, taxes owed on trust income (which in some structures must be paid before other distributions), and the remainder to the combined company's balance sheet to fund operations and the business plan.
The merger consideration issued to target equity holders is distributed upon closing through the exchange agent procedures specified in the merger agreement. Target holders who held certificated shares must surrender their certificates and complete the required letter of transmittal. Holders of uncertificated shares receive their merger consideration through the book-entry system. Earn-out shares or contingent consideration, if any, are placed in escrow or issued subject to vesting conditions and are distributed upon satisfaction of the applicable milestones after closing. The filing of the certificate of merger with the applicable state authority constitutes the effective time of the merger, and the SPAC ceases to exist as a separate entity upon the effectiveness of the certificate of merger.
Frequently Asked Questions
What is the difference between Form S-4 and Schedule 14A in a SPAC de-SPAC transaction?
A SPAC that issues shares to target company stockholders as deal consideration must register those shares on Form S-4, which is a Securities Act registration statement. Schedule 14A is the proxy statement form under the Exchange Act that governs shareholder solicitation and voting. In most de-SPAC transactions, both documents are filed together as a combined proxy statement and prospectus on Form S-4, because the SPAC is simultaneously registering new shares for the target stockholders and soliciting its own shareholders to approve the merger. If the SPAC is not issuing shares (for example, in a transaction where all target equity converts to existing SPAC shares without registration), it may file only a Schedule 14A proxy statement without the Form S-4 registration component, though this structure is less common for larger transactions.
What are the 2024 SEC rules for projection disclosure in a SPAC proxy or S-4?
The SEC's 2024 SPAC rules, which added Item 1609 to Regulation S-K, require that any financial projections included in a SPAC proxy or S-4 be accompanied by specific disclosures: the basis for the projections, the material assumptions underlying them, whether the projections reflect management's views or were prepared solely for deal purposes, and a statement as to whether the projections were used by the board or its advisors in evaluating the transaction. The rules also require disclosure of whether any projections were provided to financial advisors in connection with a fairness opinion. Issuers must state clearly that projections are inherently uncertain and that actual results may differ materially, and they must describe the material factors that could cause results to differ. Projections prepared solely for regulatory or valuation purposes that would not otherwise be disclosed may nonetheless be required if they were shared with the financial advisor or used in the board's fairness determination.
What is the Section 11 liability exposure for a SPAC S-4 registration statement?
Section 11 of the Securities Act imposes strict liability on the issuer for material misstatements or omissions in a registration statement, and subjects underwriters, directors who signed the registration statement, and experts (such as auditors and financial advisors who consent to the inclusion of their reports) to liability unless they can establish a due diligence defense. In a de-SPAC transaction, the SPAC is the registrant on the Form S-4, and its directors who sign the registration statement are exposed to Section 11 claims based on the accuracy of the target company disclosures, the financial projections, and the description of the combined company's business and risk factors. Because SPAC directors typically lack the same depth of due diligence access to the target that an underwriter in a traditional IPO would have, the adequacy of the diligence process undertaken before signing the registration statement is a material consideration in assessing Section 11 exposure.
Is a fairness opinion required in a SPAC de-SPAC transaction?
A fairness opinion is not legally required in a SPAC de-SPAC transaction under SEC rules or the Delaware General Corporation Law. However, because the board of the SPAC must evaluate whether the transaction is fair to its public shareholders, and because the proxy or S-4 must disclose the board's reasons for recommending shareholder approval, many SPAC boards obtain a fairness opinion from an independent financial advisor to support and document that determination. The fairness opinion is addressed to the SPAC board, not to shareholders, and it opines on whether the consideration to be paid by the SPAC is fair from a financial point of view to the SPAC's public shareholders. Whether a fairness opinion is obtained, and the identity and qualifications of the financial advisor providing it, must be disclosed in the proxy.
How does the redemption right process work for SPAC public shareholders?
SPAC public shareholders have the right to redeem their shares for their pro rata portion of the trust account proceeds, typically at approximately the initial offering price of $10.00 per share plus accrued interest, regardless of how they vote on the merger. To exercise the redemption right, a shareholder must tender their shares to the transfer agent by the deadline specified in the proxy statement, which is typically two business days before the shareholder vote. The proxy must describe the redemption procedure in detail, including the mechanics of tendering through DTC, the applicable deadline, the per-share redemption price, and any conditions that could affect the redemption amount. SPAC charters typically impose a maximum redemption threshold, above which the transaction cannot close, and the proxy must disclose that threshold and the potential that the transaction will not close if redemptions exceed it.
What role do ISS and Glass Lewis play in the SPAC shareholder vote?
Institutional Shareholder Services (ISS) and Glass Lewis are proxy advisory firms that provide voting recommendations to institutional investors in SPAC transactions. Their recommendations are particularly significant because institutional holders represent a meaningful portion of SPAC share ownership and many vote pursuant to advisory firm guidelines. ISS and Glass Lewis evaluate the disclosure quality of the proxy, the fairness of the transaction terms, the independence of the fairness process, the adequacy of the board's conflict disclosure, and whether the projected returns justify the consideration paid. Negative recommendations from either firm can reduce institutional support for the transaction and may increase redemptions, which can threaten the transaction's ability to close if redemptions approach the maximum threshold. SPAC sponsors typically engage with proxy advisory firms during the solicitation period to address potential concerns before recommendations are issued.
How long does the SEC review process take for a SPAC S-4 proxy?
The SEC's internal target for issuing an initial comment letter on a SPAC Form S-4 is 30 days from the date of filing. In practice, the total time from initial filing to a declaration of effectiveness ranges from two to four months for a straightforward transaction, and can extend to six months or longer for transactions that involve complex accounting issues, unusual target business structures, or multiple rounds of comments on projection disclosure, pro forma financials, or sponsor conflict disclosure. The 2024 SPAC rules added new disclosure requirements that have generated additional comment activity on projection and fairness disclosures. SPAC sponsors and their counsel should plan the transaction timeline with sufficient buffer to accommodate two to three rounds of SEC comments before the target effectiveness date.
What happens between shareholder approval and transaction closing in a de-SPAC?
After the shareholders vote to approve the merger, the SPAC and target must satisfy any remaining closing conditions set out in the merger agreement, which may include regulatory approvals (such as Hart-Scott-Rodino clearance if applicable), third-party consents, and the delivery of officer certificates and legal opinions. The SPAC must also process redemption elections from shareholders who elected to redeem and disburse those funds from the trust. Once all conditions are satisfied, the parties execute the merger or closing documents, the consideration is distributed to target equity holders, the trust account is released to fund the combined company's balance sheet, and the SPAC's shares are converted into shares of the combined public company. The post-vote closing period typically runs from a few days to several weeks, depending on the number of outstanding conditions and the efficiency of the parties' counsel and transfer agents.
Related Reading
Counsel for SPAC Proxy and S-4 Preparation
Acquisition Stars advises SPAC sponsors, targets, and their boards on de-SPAC proxy and Form S-4 preparation, SEC comment letter strategy, projection disclosure under the 2024 rules, conflict disclosure, and transaction execution through closing. Submit your transaction details for an initial assessment.